Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Modern Diagnost.
Quarter-by-quarter operating performance
Financials of Modern Diagnost.
Annual income statement trend
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 60.21 | 56.28 | 67.13 | 77.95 | 83.11 |
| Expenses + | 54.19 | 57.26 | 55.99 | 59.99 | 70.52 |
| Operating Profit | 6.02 | -0.98 | 11.14 | 17.96 | 12.59 |
| OPM % | 10.00% | -1.74% | 16.59% | 23.04% | 15.15% |
| Other Income + | 0.35 | 0.32 | 1.46 | 0.86 | 1.03 |
| Interest | 1.57 | 1.41 | 1.81 | 1.91 | 2.44 |
| Depreciation | 3.66 | 3.87 | 3.92 | 4.19 | 5.19 |
| Profit before tax | 1.14 | -5.94 | 6.87 | 12.72 | 5.99 |
| Tax % | 227.19% | -3.54% | 15.57% | 29.48% | 12.19% |
| Net Profit + | -1.45 | -5.73 | 5.79 | 8.97 | 5.25 |
| EPS in Rs | -14.50 | -57.30 | 57.90 | 8.15 | 3.48 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials of Modern Diagnost.
Capital structure and asset base
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 1.00 | 1.00 | 1.00 | 11.00 | 15.10 |
| Reserves | 10.70 | 4.96 | 10.76 | 9.73 | 43.45 |
| Borrowings + | 20.40 | 15.31 | 20.46 | 22.09 | 37.10 |
| Other Liabilities + | 16.60 | 15.27 | 17.26 | 21.76 | 22.95 |
| Total Liabilities | 48.70 | 36.54 | 49.48 | 64.58 | 118.60 |
| Fixed Assets + | 24.31 | 23.67 | 27.04 | 30.65 | 48.10 |
| CWIP | 0.75 | 0.00 | 3.60 | 8.95 | 10.18 |
| Investments | 5.29 | 0.11 | 0.21 | 0.23 | 16.97 |
| Other Assets + | 18.35 | 12.76 | 18.63 | 24.75 | 43.35 |
| Total Assets | 48.70 | 36.54 | 49.48 | 64.58 | 118.60 |
Financials of Modern Diagnost.
Operating, investing and financing cash movement
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | 3.64 | -0.12 | 7.93 | 13.73 | |
| Cash from Investing Activity + | -5.20 | 2.11 | -11.03 | -13.14 | |
| Cash from Financing Activity + | 4.50 | -6.47 | 3.36 | -0.22 | |
| Net Cash Flow | 2.94 | -4.48 | 0.26 | 0.37 | |
| Free Cash Flow | -1.49 | -3.27 | -3.04 | 0.58 | |
| CFO/OP | 52% | 12% | 60% | 98% |
Financials of Modern Diagnost.
Working capital efficiency and return ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 54.56 | 52.27 | 56.28 | 59.75 | 69.30 |
| Inventory Days | 25.90 | 40.62 | 61.45 | 95.47 | 119.58 |
| Days Payable | 172.38 | 170.83 | 177.12 | 160.28 | 196.43 |
| Cash Conversion Cycle | -91.92 | -77.94 | -59.39 | -5.06 | -7.55 |
| Working Capital Days | -43.95 | -58.82 | -34.74 | -41.53 | -43.87 |
| ROCE % | -17.24% | 32.75% | 38.99% | 12.18% |
Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…
IHH plans to increase its stake in Fortis to over 50% within 3-5 years, supporting long-term strategic growth. Key concall takeaways from Fortis Healthcare…
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…